Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19.

Tang, Kefu; Wang, Lu; Shen, Lu; He, Lin; Wu, Xi

Tang, Kefu; Wang, Lu; Shen, Lu; He, Lin; Wu, Xi.

Tang K; Prenatal Diagnosis Center, Department of Clinical Laboratory, Changning Maternity and Infant Health Hospital, East China Normal University, Shanghai, 200051, China.
Wang L; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China.
Shen L; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China.
He L; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. helin@sjtu.edu.cn.
Wu X; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. wuxi0901@sjtu.edu.cn.

Sci China Life Sci ; 65(12): 2560-2563, 2022 12.

Article in English | MEDLINE | ID: covidwho-1906487

Subject(s)

COVID-19; Humans; SARS-CoV-2; Tomography, X-Ray Computed; Fibrosis; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Sci China Life Sci Journal subject: Biology / Science Year: 2022 Document Type: Article Affiliation country: S11427-021-2138-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google